dimethyldioctadecylammonium has been researched along with HIV Coinfection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andersen, P; Andreasen, LV; Bang, P; Fomsgaard, A; Gram, G; Karlsson, I; Kromann, I; Schou, C; Tang, S | 1 |
1 other study(ies) available for dimethyldioctadecylammonium and HIV Coinfection
Article | Year |
---|---|
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
Topics: Adjuvants, Immunologic; AIDS Vaccines; Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes; Dogs; Drug Evaluation, Preclinical; Enzyme-Linked Immunospot Assay; Epitopes, T-Lymphocyte; Female; Glycolipids; HIV Infections; HIV-1; HLA-A2 Antigen; Immunity, Cellular; Immunization; Male; Mice; Mice, Knockout; Molecular Sequence Data; Peptides; Quaternary Ammonium Compounds; Swine; Swine, Miniature; T-Lymphocytes, Cytotoxic; Toxicity Tests | 2011 |